The basics of the prevention and treatment of dry eye syndrome in patients with diabetes mellitus

DOI: https://doi.org/10.29296/25877305-2019-04-11
Download full text PDF
Issue: 
4
Year: 
2019

V. Shishkova , Candidate of Medical Sciences Center for Speech Pathology and Neurorehabilitation, Moscow Healthcare Department, Moscow A.I. Evdokimov Moscow State University of Medicine and Dentistry

The health status of patients with diabetes mellitus (DM) and their quality of life directly depends on their daily well-being and on the uncomfortable conditions that may not be so noticeable in the presence of macrovascular complications, but nevertheless, can cause great suffering. The cause of daily discomfort can be dry eye syndrome (DES), a set of corneal and conjunctival changes caused by systematic instability of the tear film. The current treatment and prevention strategies for DES involve the use of drugs that moisturize the eye surface. There is a wide range of tear substitutes on the market; however, when making a choice, it is important to remember that the drug should be long present on the eye surface and therefore the absence of drug components can have a negative impact on the eye.
Keywords: 
endocrinology
ophthalmology
diabetes mellitus
dry eye syndrome
HYLOPARIN-COMOD®
PARIN-POS®

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. International Diabetes Federation, Diabetes Atlas, 5th ed. International Diabetes Federation; 2011.
  2. Dedov I.I., Shestakova M.V. Saharnyj diabet / M: Meditsinskoe Informatsionnoe Agenstvo, 2005; 677 s. [Dedov I.I., Shestakova M.V. Sakharnyi diabet / M: Meditsinskoe Informatsionnoe Agenstvo, 2005; 677 s. (in Russ.)].
  3. Stamler J., Vaccaro O., Neaton J. et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial // Diabetes Care. – 1993; 16 (2): 434–44.
  4. Brzheskij V.V., Somov E.E. Rogovichno-kon'junktival'nyj kseroz / SPb, 2003; 119 s. [Brzheskii V.V., Somov E.E. Rogovichno-kon"yunktival'nyi kseroz / SPb, 2003; 119 p. (in Russ.)].
  5. Manaviat M. et al. Prevalence of dry eye syndrome and diabetic retinopathyin type 2 diabetic patients // BMC Ophthalmology. – 2008; 8: Article 10.
  6. Loginov G.N. Mestnaja zamestitel'naja terapija Vidisikom pri sindrome «suhogo glaza» u lits, stradajuschih saharnym diabetom. Mat-ly HI Rossijskogo natsional'nogo kongressa «Chelovek i lekarstvo» / M., 2004; s. 188 [Loginov G.N. Mestnaya zamestitel'naya terapiya Vidisikom pri sindrome «sukhogo glaza» u lits, stradayushchikh sakharnym diabetom. Mat-ly KhI Rossiiskogo natsional'nogo kongressa «Chelovek i lekarstvo» / M., 2004; p. 188 (in Russ.)].
  7. Akinci A., Cetinkaya E., Aycan Z. Dry eye syndrome in diabetic children // Eur. J. Ophthalmol. – 2007; 17 (6): 873–8.
  8. Oftal'mologija. Natsional'noe rukovodstvo. Pod. red. S.E. Avetisova, E.A. Egorova, L.K. Moshetovoj, V.V. Neroeva, H.P. Tahchidi / M.: GEOTAR-Media, 2018; 944 c. [Oftal'mologiya. Natsional'noe rukovodstvo. Pod. red. S.E. Avetisova, E.A. Egorova, L.K. Moshetovoi, V.V. Neroeva, Kh.P. Takhchidi / M.: GEOTAR-Media, 2018; 944 p. (in Russ.)]
  9. Somov E.E., Brzheskij V.V. Kratkoe rukovodstvo po obsledovaniju i lecheniju bol'nyh s sindromom «suhogo glaza» / SPb: Vel', 2003; 32 s. [Somov E.E., Brzheskii V.V. Kratkoe rukovodstvo po obsledovaniyu i lecheniyu bol'nykh s sindromom «sukhogo glaza» / SPb: Vel', 2003; 32 p. (in Russ.)].
  10. Achtsidis V. et al. Dry eye syndrome in subjects with diabetes and association with neuropathy // Diabetes Care. – 2014; 37 (10): 210–1.
  11. Baudouin C. et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the ocean group meeting // The Ocular Surface. – 2013; 11 (4): 246–58.
  12. Fuerst N. et al. Tear osmolarity and dry eye symptoms in diabetics // Clin. Ophthalmol. – 2014; 8: 507–15.
  13. Figueroa-Ortiza L., Rodrnguezb E., Garcna-Benc A. Study of tear function and the conjunctival surface in diabetic patients // Arch. SOC Esp. Oftalmol. – 2011; 86 (4): 107–12.
  14. Ermakova N.A. Sindrom «suhogo glaza» u bol'nyh saharnym diabetom. XI Vserossijskaja nauchno-prakticheskaja konferentsija s mezhdunarodnym uchastiem «Fedorovskie chtenija – 2013». Sb. tez.dokl. Pod red. B.E. Maljugina / M.: Oftal'mologija, 2013; s. 209 [Ermakova N.A. Sindrom «sukhogo glaza» u bol'nykh sakharnym diabetom. XI Vserossiiskaya nauchno-prakticheskaya konferentsiya s mezhdunarodnym uchastiem «Fedorovskie chteniya – 2013». Sb. tez.dokl. Pod red. B.E. Malyugina / M.: Oftal'mologiya, 2013; p. 209 (in Russ.)].
  15. Najafi L. Dry eye and its correlation to diabetes microvascular complications in people with type 2 diabetes mellitus // J. Diabetes Complications. – 2013; 27 (5): 459–62.
  16. Teping Ch., Bischoff G. Treatment of sicca syndrome – effective and well-tolerated also with contact lenses // Drug Report: Hyaluronic acid. – 2010; 4 (2): 15.
  17. HILOPARIN–KOMOD® Rastvor uvlazhnjajuschij oftal'mologicheskij. Instruktsija po primeneniju [HILOPARIN–SOMOD® Rastvor uvlazhnyayushchii oftal'mologicheskii. Instruktsiya po primeneniyu (in Russ.)].
  18. Teping C., Wiedemann B. Das Comod' System. Einkonservierungsmittelfreies Mehrdosenbehaltnis fur Augentropfen // Klin. Monatsbl. Augenheilkd. – 1994; 205: 210–7.
  19. Mousavi S., Moradi M., Khorshidahmad T. et al. Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review // Adv. Pharmacol. Sci. – 2015; 2015: Article ID 507151.
  20. Knorr M., Wunderlich K., Steuhl K. et al. Wirkung von Heparin und Ascorbinsure auf das Wachstumsverhaltenkultivierter Hornhautepithelzellen des Kaninchens // Der Ophthalmologe. – 1996; Bd. 93: 275–8.
  21. Egorov E.A., Romanova T.B., Kats D.V. i dr. Primenenie rastvora Hiloparin-Komod® v oftal'mologicheskoj praktike (pilotnoe issledovanie) // RMZh. Klinicheskaja oftal'mologija. – 2014; 4: 207–12 [Egorov E.A., Romanova T.B., Katz D.V. et al. Application of the solution HYLOPARIN-COMOD® in ophthalmological practice (pilot study) // RMJ. Clinical ophthalmology. – 2014; 4: 207–12 (in Russ.)].
  22. Tkachenko N.V., Astahov S.Ju. Opyt primenenija «Hiloparina» v klinicheskoj praktike // Oftal'mol. ved. – 2014; 7 (4): 53–62 [Tkachenko N.V., Astakhov S.Yu. The experience of «Hyloparin» use in clinical practice // Ophthalmology journal (Oftal’mol. ved.). – 2014; 7 (4): 53–62 (in Russ.)].
  23. Egorov E.A., Romanova T.B., Oganezova Zh.G. i dr. Rezul'taty primenenija geparin-soderzhaschego smazyvajuschego sredstva v lechenii sindroma «suhogo glaza» // RMZh. Klinicheskaja oftal'mologija. – 2017; 3: 135–40 [Egorov E.A., Romanova T.B., Oganezova J.G. et al. Results of application of heparin-containing lubricant in the treatment of dry eye syndrome // RMJ. Clinical ophthalmology. – 2017; 3: 135–40 (in Russ.)].